Compare Affirm Holdings Inc (AFRM) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs Bristol-Myers Squibb Co — how do they compare? Affirm Holdings Inc trades at $77.35 (market cap $25.69B), while Bristol-Myers Squibb Co trades at $63.52 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 5.1× Affirm Holdings Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.
| AFRM | BMY | |
|---|---|---|
Market Cap | $25.69B | $129.94B |
Sector | Financials | Health |
52-Week High | $92.18 | $65.89 |
52-Week Low | $42.53 | $42.60 |
Enterprise Value | $32.30B | $163.92B |
Dividend Yield | — | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
